-
Case Studies
Retinol (Vitamin A) – Ingredient Insights
This report explores the impact of retinol (vitamin A) across the FMCG space. Retinol is one of the most studied ingredients in personal care and has a plethora of health benefits, while it does pose risks when overused or used on premature skin.
-
Product Insights
Vitamin D Deficiency Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Vitamin D Deficiency Disorders - Drugs In Development, 2023’, provides an overview of the Vitamin D Deficiency Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vitamin D Deficiency Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval Analysis for Anemia
Overview How likely is it that the drugs in Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anemia Overview Anemia is a condition characterized by insufficient healthy red blood cells...
-
Product Insights
NewLikelihood of Approval Analysis for Macular Degeneration
Overview How likely is it that the drugs in Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Macular Degeneration Overview Macular degeneration is primarily an age-related retinal condition. There...
-
Product Insights
NewLikelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Disorders
Overview How likely is it that the drugs in Bone Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Disorders Overview Bones tend to become weaker or loosen their strength...
-
Company Insights
Innovation and Patenting activity of Riken Vitamin Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Riken Vitamin Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval Analysis for Hypoparathyroidism
Overview How likely is it that the drugs in Hypoparathyroidism will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypoparathyroidism Overview Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of...
-
Product Insights
NewLikelihood of Approval Analysis for Post Menopausal Osteoporosis
Overview How likely is it that the drugs in Post Menopausal Osteoporosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Menopausal Osteoporosis Overview Postmenopausal osteoporosis is the most common form...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gildeuretinol Acetate in Geographic Atrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gildeuretinol Acetate in Geographic Atrophy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gildeuretinol Acetate in Geographic Atrophy Drug Details: Gildeuretinol acetate (ALK-001) is...